Barron's Cover

Jack Hough

CBS Chief Les Moonves likely could find huge synergies from combining with Viacom. With or without a deal, CBS shares could double by 2020.

Up & Down Wall St.

Randall W. Forsyth

Taxes, health care, and energy likely to be flashpoints in the first Clinton-Trump debate

Streetwise

Ben Levisohn

Some Fed watchers decried the decision to leave interest rates unchanged. But raising rates shouldn’t be something that’s done in haste. Here’s why, and a better plan.

Interview

Leslie P. Norton

Clinton and Trump both want to boost infrastructure spending. Jamie Cook, of CSFB, picks industry winners.

Feature

Lawrence C. Strauss

The financial-services hybrid ought to get more respect for its card business. The stock could return 20%.

Alternative Investments

Sarah Max

Richard Merage’s hedge fund looks at companies through the lens of a business owner. Bullish on Sprint.

Feature

Jack Willoughby

Low-cost Spirit Airlines offers no amenities, cramped seats, and a stock that could fly as much as 60%.

Small Caps

David Englander

The distributor of aerospace parts is poised to benefit from a new aircraft-maintenance cycle, which could help lift the stock price more than 30%.

The Best Advice

Steve Garmhausen

Signature Estate Investment Advisors’ Brian Holmes provides holistic financial planning, healthy returns.

Editorial Commentary

Thomas G. Donlan

Disasters shift supply and demand, creating opportunities and pitfalls for those that exploit them.

The Trader

Vito J. Racanelli

Low rates, higher earnings, and seasonal strength could bode well for U.S. shares this fall.

Trader Extra

Vito J. Racanelli

For years this column has been skeptical of the once sky-high equity valuation of Whole Foods. Now that the stock is down, shares look tasty.

Trader Extra

Vito J. Racanelli

Health-care costs are denting dining-out spending for consumers.

International Trader - Europe

Jonathan Buck

The Swiss-based company, which has expanded rapidly, boasts a 24% market share in airport travel retail. The stock looks inexpensive.

International Trader - Asia

Shuli Ren

The Bank of Japan’s new monetary strategy won’t help local banks much.

Emerging Markets

Dimitra DeFotis

A grand new infrastructure spending plan is designed to jump-start private investment as the economy emerges from recession.

The Striking Price

Steven M. Sears

Options investors bet that battered stock will keep falling. Bank’s problems include possibility of huge fine from U.S. regulators.

Current Yield

Amey Stone

With rising interest rates likely later this year, floating-rate bank loans look like a good deal. Here’s what you need to know.

Commodities Corner

Rhiannon Hoyle

Lead, an industrial mainstay, could benefit as traders switch to it from more expensive zinc and tin to play metals rally.

Technology Trader

Tiernan Ray

Traditional auto parts companies will likely play a big role in autonomous car, and their stocks are dirt cheap.

Digital Investor

Theresa W. Carey

The online broker upgrades its site; also, thinkorswim trading challenge for students; and Siebert changes hands.

Economic Beat

Gene Epstein

Charging cars and trucks for their contribution to congestion on roads and bridges—and planes for their contribution to congestion on runways—would shift the cost of infrastructure to users from taxpayers.

Speaking of Dividends

Avi Salzman

Stocks get hit by patent expirations and pricing fears. But the companies still generate abundant cash flow and are growing their dividends.

ETF Focus

Chris Dieterich

ETFs that aim to deliver the opposite of the volatility index, or VIX, should be handled with extreme care. But they will deliver gains as long as market swoons are short and sweet.

Fund of Information

Lawrence C. Strauss

Insider-trading allegations come atop performance woes that just now appear to be abating.

Other Voices

Dick Larkin

Puerto Rico’s financial problems seem overwhelming, but the island commonwealth can heal itself.

Review

A trend toward working at home and shopping on the web are biting into restaurant profits.

Preview

The market’s trajectory in the three months before the vote is the key factor. Right now, that’s a bad omen for Hillary Clinton.

Follow Up

Barron’s was right: After a prolonged process Sarepta’s muscular dystrophy drug was cleared by the FDA, driving shares up more than 100%.